To determine the treatment effect of triple-combination therapy in 6-8 year olds after
presumed FDA approval, using rapid structural and functional pulmonary and abdominal MRI (UTE
and 129Xe).
Phase:
Phase 4
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborators:
University of Iowa University of Kansas University of Virginia